The FTC and seven states have filed a lawsuit against Ticketmaster, alleging the company allowed ticket brokers to exploit fans by reselling tickets at inflated prices. This lawsuit follows Ticketmaster's controversial handling of the Eras tour ticket sales.
In a surprising policy shift, President Trump has directed a ban on TV drug advertising, a move that could reshape the pharmaceutical landscape and impact major networks. Discover the implications of this controversial decision!
In a shocking turn of events, Delta and United Airlines are facing lawsuits for charging premium prices for window seats that lack actual windows. Passengers claim they were misled and are seeking justice. Join the growing outrage!
In a pivotal moment for the crypto world, President Trump has signed the GENIUS Act, creating a regulatory framework for stablecoins and drawing a sharp contrast with the Biden administration. This bipartisan legislation aims to bolster the crypto industry while addressing concerns over consumer protection and data privacy.
In a controversial ruling, a federal judge has allowed medical debt to stay on Americans' credit reports, overturning a Biden-era policy aimed at alleviating financial burdens for millions. Advocacy groups express dismay over the decision, while credit bureaus laud it as a protection for lenders.
FICO is set to include buy now, pay later loans in credit scores, impacting how lenders assess creditworthiness. This change reflects a rising trend in consumer finance, but could it help or hurt your score?
Experts warn that the new 'Big, Beautiful Bill' could have significant consequences for taxpayers, gamblers, and consumers. With changes to deductions and cuts to consumer protections, many Americans may face unexpected financial burdens.
In a surprising turn of events, the Senate voted 99-1 to defeat a ban on state-level AI regulations, marking a significant victory for consumer protection advocates and raising concerns among tech companies.
Anne Wojcicki's nonprofit has won the bid to buy 23andMe, raising critical questions about the future of genetic data privacy. Experts warn that sensitive DNA information could be at risk.
In a stunning move, Cara Petersen resigns as the CFPB's acting enforcement director, criticizing the Trump administration's efforts to undermine the agency and its mission to protect consumers.
